FMC Secures $400M Equity Investment from Tessenderlo, Concluding Strategic Review
FMC is trading near its 52-week low of $10.715 (9.5% above the low).
Summary
FMC Corporation secured a $400 million minority equity investment from Tessenderlo Group at $13.30 per share, giving Tessenderlo approximately 20% ownership. This significant capital infusion concludes FMC's strategic options review and is crucial for achieving its $1 billion debt paydown target. The investment follows a period of financial strain, including a Q1 net loss of $281 million, a credit agreement amendment for covenant relief, and recent debt refinancing efforts totaling $1.2 billion in senior secured notes. This move substantially improves FMC's financial flexibility and liquidity, positioning the company to execute its strategic plan.
At the time of this announcement, FMC was trading at $11.73 on NYSE in the Life Sciences sector, with a market capitalization of approximately $1.4B. The 52-week trading range was $10.72 to $44.68. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: PR Newswire.